Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease

Judith Wellens, Matthew Edmans, Uri Obolski, Colleen Gc McGregor, Peter Simmonds, Marc Turner, Lisa Jarvis, Donal Skelly, Susanna Dunachie, Eleanor Barnes, David W. Eyre, Jean Frederic Colombel, Serre Yu Wong, Paul Klenerman, James O. Lindsay, Jack Satsangi, Craig P. Thompson

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)1919-1922
Number of pages4
Issue number9
StatePublished - 1 Sep 2022


  • IBD
  • immune response
  • infectious disease

Cite this